These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24787432)

  • 1. Targeted proteomics pipeline reveals potential biomarkers for the diagnosis of metastatic lung cancer in pleural effusion.
    Chen CD; Wang CL; Yu CJ; Chien KY; Chen YT; Chen MC; Chang YS; Wu CC; Yu JS
    J Proteome Res; 2014 Jun; 13(6):2818-29. PubMed ID: 24787432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive proteome analysis of malignant pleural effusion for lung cancer biomarker discovery by using multidimensional protein identification technology.
    Yu CJ; Wang CL; Wang CI; Chen CD; Dan YM; Wu CC; Wu YC; Lee IN; Tsai YH; Chang YS; Yu JS
    J Proteome Res; 2011 Oct; 10(10):4671-82. PubMed ID: 21806062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An MRM-Based Cytokeratin Marker Assay as a Tool for Cancer Studies: Application to Lung Cancer Pleural Effusions.
    Perzanowska A; Fatalska A; Wojtas G; Lewandowicz A; Michalak A; Krasowski G; Borchers CH; Dadlez M; Domanski D
    Proteomics Clin Appl; 2018 Mar; 12(2):. PubMed ID: 29352525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Untargeted mass spectrometry-based metabolomic profiling of pleural effusions: fatty acids as novel cancer biomarkers for malignant pleural effusions.
    Lam CW; Law CY
    J Proteome Res; 2014 Sep; 13(9):4040-6. PubMed ID: 25117182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of endostatin for malignant pleural effusion: A clinical study and meta-analysis.
    Tian P; Shen Y; Feng M; Zhu J; Song H; Wan C; Chen L; Wen F
    Postgrad Med; 2015 Jun; 127(5):529-34. PubMed ID: 25979108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.
    Wang Y; Chen Z; Chen J; Pan J; Zhang W; Pan Q; Ding H; Lin X; Wen X; Li Y; Meng QH
    Clin Chim Acta; 2013 Jun; 421():230-5. PubMed ID: 23523589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control.
    Qian Q; Zhan P; Sun WK; Zhang Y; Song Y; Yu LK
    Neoplasma; 2012; 59(4):433-9. PubMed ID: 22489699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing pleural effusions using mass spectrometry-based multiplexed targeted proteomics quantitating mid- to high-abundance markers of cancer, infection/inflammation and tuberculosis.
    Robak A; Kistowski M; Wojtas G; Perzanowska A; Targowski T; Michalak A; Krasowski G; Dadlez M; Domański D
    Sci Rep; 2022 Feb; 12(1):3054. PubMed ID: 35197508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomics revealed protein biomarkers to distinguish malignant pleural effusion from benign pleural effusion.
    Dong T; Liang Y; Chen H; Li Y; Li Z; Gao X
    J Proteomics; 2024 Jun; 302():105201. PubMed ID: 38768894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of tumor markers in lung adenocarcinoma-associated cytologically negative pleural effusions.
    Hsieh TC; Huang WW; Lai CL; Tsao SM; Su CC
    Cancer Cytopathol; 2013 Sep; 121(9):483-8. PubMed ID: 23408492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of retinoblastoma-associated binding protein 46 as a novel prognostic marker for distant metastasis in nonsmall cell lung cancer by combined analysis of cancer cell secretome and pleural effusion proteome.
    Wang CL; Wang CI; Liao PC; Chen CD; Liang Y; Chuang WY; Tsai YH; Chen HC; Chang YS; Yu JS; Wu CC; Yu CJ
    J Proteome Res; 2009 Oct; 8(10):4428-40. PubMed ID: 19655816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.
    Görgün D; Seçik F; Midilli K; Akkaya V; Yıldız P
    Respir Med; 2013 Aug; 107(8):1260-5. PubMed ID: 23791464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qualification and Verification of Serological Biomarker Candidates for Lung Adenocarcinoma by Targeted Mass Spectrometry.
    Wu HY; Goan YG; Chang YH; Yang YF; Chang HJ; Cheng PN; Wu CC; Zgoda VG; Chen YJ; Liao PC
    J Proteome Res; 2015 Aug; 14(8):3039-50. PubMed ID: 26120931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic and lipidomic characterization of malignant pleural effusion in human lung cancer.
    Yang Z; Song Z; Chen Z; Guo Z; Jin H; Ding C; Hong Y; Cai Z
    J Pharm Biomed Anal; 2020 Feb; 180():113069. PubMed ID: 31884394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential biomarkers for antidiastole of tuberculous and malignant pleural effusion by proteome analysis.
    Shi J; Li P; Zhou L; Qi S; Wang B; Li D; Duan L; Chen WX; Xia J; Zou L; Yang S
    Biomark Med; 2019 Feb; 13(2):123-133. PubMed ID: 30791695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.
    Biaoxue R; Min L; Tian F; Wenlong G; Hua L
    BMC Pulm Med; 2018 Dec; 18(1):188. PubMed ID: 30522463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of HER-2/neu protein in malignant pleural effusion-associated lung adenocarcinoma and as a tumor marker in pleural effusion diagnosis.
    Hung TL; Chen FF; Liu JM; Lai WW; Hsiao AL; Huang WT; Chen HH; Su WC
    Clin Cancer Res; 2003 Jul; 9(7):2605-12. PubMed ID: 12855637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-depth proteomic analysis of six types of exudative pleural effusions for nonsmall cell lung cancer biomarker discovery.
    Liu PJ; Chen CD; Wang CL; Wu YC; Hsu CW; Lee CW; Huang LH; Yu JS; Chang YS; Wu CC; Yu CJ
    Mol Cell Proteomics; 2015 Apr; 14(4):917-32. PubMed ID: 25638566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Exploration of Peptide Biomarkers in Malignant Pleural Effusion of Lung Cancer Using Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry.
    Xu J; Xu B; Tang C; Li X; Qin H; Wang W; Wang H; Wang Z; Li L; Li Z; Gao H; He K; Liu X
    Dis Markers; 2017; 2017():3160426. PubMed ID: 28386154
    [No Abstract]   [Full Text] [Related]  

  • 20. High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients.
    Tang Y; Wang Z; Li Z; Kim J; Deng Y; Li Y; Heath JR; Wei W; Lu S; Shi Q
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2544-2549. PubMed ID: 28223509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.